申请人:BOEHRINGER INGELHEIM INTERNATIONAL GMBH
公开号:EP2332963A2
公开(公告)日:2011-06-15
Disclosed is a process for preparing a macrocyclic compound of the formula (I) wherein a hydroxyl-substituted macrocyclic compound of formula (3) is reacted with a sulfonyl-substituted compound of formula QUIN:
The compounds of formula (I) are potent active agents for the treatment of hepatitis C virus (HCV) infection.
本发明公开了一种制备式(I)大环化合物的工艺,其中式(3)的羟基取代的大环化合物与式 QUIN 的磺酰基取代的化合物反应:
式(I)化合物是治疗丙型肝炎病毒(HCV)感染的强效活性剂。